Washington DC

D.C. Entheogen Initiative 81 Has Projected Law Date Sent to Congress

Washington D.C.’s Initiative 81, the Entheogenic Plant and Fungus Policy Act of 2020, was formally brought before Congress on February 1 for a mandated review period of 30 legislative days, Decriminalize Nature DC announced on Wednesday. 

Congress is expected to approve and implement the initiative by the “Projected Law Date” of March 19, 2021.

Residents of Washington D.C. voted for a progressive drug policy change in the U.S. capital during the November elections, making possession of entheogenic plants and fungi the lowest law enforcement priority with a sweeping poll result of 76 percent in favour. “This change helps ensure that DC residents benefiting from plant and fungi medicines will not face investigation, arrest or incarceration,” the press release says.

D.C. became the fifth jurisdiction after Denver, Ann Arbor, Santa Cruz, and Oakland to decriminalize possession of entheogenic plants on November 3, 2020. Initiative 81, officially presented to the D.C. Board of Elections in 2019 by Decriminalize Nature, will decriminalize simple possession of entheogens. Those naturally occurring plants include psilocybin mushrooms, psilocin, mescaline-producing cacti, ayahuasca, and iboga. 

Since the District of Columbia is a federal town governed under D.C.’s Home Rule Act, Congressional jurisdiction applies throughout the District. This means the Entheogenic Plant and Fungus Policy Act of 2020 requires a Congressional overview to become a law. “Overturning the legislation would require a majority vote in both the House and the Senate, both of which are controlled by Democrats,” the press release states. 

See Also
Oklahoma psilocybin bill image

The victory in Washington D.C., in step with the passing of Measures 109 and 110 in Oregon, have spurred nationwide calls for the rescheduling of controlled substances, with action being seen on almost daily basis in recent weeks. Decriminalize Nature Massachusetts and Bay Staters for Natural Medicine are currently working hard both at the state and individual municipal levels in Massachusetts. Treatment First Washington in Washington State is organizing a press event on February 4 with several state legislators.

With 2021 now well underway, the movement for drug policy reform has taken the front seat, inspiring city councils and state legislatures to decriminalize possession, while letting people benefit from the easy access to plant medicines. So far, Hawaii and Florida have introduced state bills, while Somerville, Massachusetts joined other cities in the decriminalization movement.

What makes peyote unique among psychedelics?

Lophos Pharma is a #peyote focused psychedelics company co-founded by wife and husband duo Claire and Evan Stawnyczy to explore mescaline’s therapeutic potential.

Read the full interview here: http://ow.ly/kN6w50I3vzt

The push for medical #DMT is on. Truffle Report looks at top corporate and scientific developments involving the spirit molecule from @mindmedco, @AlgernonPharma, @entheonbiomed, @SmallPharma and more.

Full article here: http://ow.ly/khee50HXOHz

#science #business #medicine

Our CEO and Co-Founder @flobrand spoke to @amanda_siebert @Forbes to give deeper context on the significance of our donation to @MAPS and the importance of collaboration between for-profit and non-profits in tackling the #mentalhealth crisis.

See: https://www.forbes.com/sites/amandasiebert/2022/02/16/exclusive-maps-accepts-500k-donation-from-atai-life-sciences-philanthropy-arm/

A Hawaii legislative committee has approved a bill that proposes the establishment of a working group to study the therapeutic benefits of #psilocybin by a vote of 5-0.

Read the full story here: http://ow.ly/4WWI50HWJtL

#psychedelics #healing #medicine #hawaii #legal

"Inspired by a device created by in the 1950s, the creators hope to bring free transcendental experiences to 100,000 Britons – and unite the country through communal hallucinations"


Load More...

Related Articles

Scroll To Top